Kindred Healthcare (NYSE:KND) saw some unusual options trading on Monday. Stock investors acquired 727 call options on the company. This represents an increase of approximately 1,246% compared to the typical daily volume of 54 call options.
KND has been the topic of a number of research reports. Mizuho set a $9.00 target price on Kindred Healthcare and gave the company a “hold” rating in a report on Monday, December 18th. Zacks Investment Research upgraded Kindred Healthcare from a “hold” rating to a “buy” rating and set a $11.00 target price on the stock in a report on Wednesday, January 10th. Three research analysts have rated the stock with a sell rating, six have given a hold rating and one has given a buy rating to the company. Kindred Healthcare currently has a consensus rating of “Hold” and a consensus price target of $9.31.
Large investors have recently added to or reduced their stakes in the stock. Two Sigma Advisers LP acquired a new position in Kindred Healthcare in the fourth quarter worth approximately $109,000. Engineers Gate Manager LP acquired a new position in Kindred Healthcare in the fourth quarter worth approximately $153,000. Highbridge Capital Management LLC acquired a new position in Kindred Healthcare in the third quarter worth approximately $133,000. Investors Research Corp acquired a new position in Kindred Healthcare in the fourth quarter worth approximately $239,000. Finally, Caption Management LLC acquired a new position in Kindred Healthcare in the fourth quarter worth approximately $272,000. Hedge funds and other institutional investors own 88.97% of the company’s stock.
Shares of KND opened at $8.85 on Tuesday. Kindred Healthcare has a fifty-two week low of $5.50 and a fifty-two week high of $11.90. The stock has a market capitalization of $813.58, a PE ratio of 26.03 and a beta of 1.12. The company has a debt-to-equity ratio of 9.05, a quick ratio of 1.50 and a current ratio of 1.52.
Kindred Healthcare (NYSE:KND) last released its quarterly earnings data on Wednesday, February 28th. The health services provider reported $0.20 EPS for the quarter, topping analysts’ consensus estimates of $0.18 by $0.02. Kindred Healthcare had a positive return on equity of 4.64% and a negative net margin of 11.16%. The firm had revenue of $1.48 billion for the quarter, compared to the consensus estimate of $1.48 billion. During the same quarter in the prior year, the company posted $0.05 earnings per share. The firm’s revenue was down 2.2% on a year-over-year basis. sell-side analysts expect that Kindred Healthcare will post 0.75 EPS for the current fiscal year.
COPYRIGHT VIOLATION WARNING: “Stock Traders Buy High Volume of Call Options on Kindred Healthcare (KND)” was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of United States and international trademark & copyright law. The legal version of this piece of content can be read at https://www.dispatchtribunal.com/2018/04/10/stock-traders-buy-high-volume-of-call-options-on-kindred-healthcare-knd.html.
Kindred Healthcare Company Profile
Kindred Healthcare, Inc provides healthcare services in the United States. It operates through five segments: Home Health Services, Hospice Services, Hospitals, Kindred Hospital Rehabilitation Services, and RehabCare. The company provides long-term acute care (LTAC) services to post-intensive care and medically complex patients, including the critically ill and suffering from multiple organ system failures most commonly of the cardiovascular, pulmonary, kidney, gastro-intestinal, and cutaneous systems.
Receive News & Ratings for Kindred Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.